These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours. McDowell H; Peuchmaur M; Dominici C; Flamant F Anticancer Res; 1993; 13(5C):1863-6. PubMed ID: 7903523 [TBL] [Abstract][Full Text] [Related]
9. Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60/DNR cell line. Zhou DC; Marie JP; Maisonneuve L; Faussat-Suberville AM; Zittoun R Exp Hematol; 1993 Jun; 21(6):779-84. PubMed ID: 8099018 [TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856 [TBL] [Abstract][Full Text] [Related]
11. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Chaudhary PM; Roninson IB Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276 [TBL] [Abstract][Full Text] [Related]
12. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093 [TBL] [Abstract][Full Text] [Related]
13. Genes amplified and overexpressed in human multidrug-resistant cell lines. Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906 [TBL] [Abstract][Full Text] [Related]
14. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092 [TBL] [Abstract][Full Text] [Related]
15. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823 [TBL] [Abstract][Full Text] [Related]
16. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Zhou DC; Marie JP; Suberville AM; Zittoun R Leukemia; 1992 Sep; 6(9):879-85. PubMed ID: 1355575 [TBL] [Abstract][Full Text] [Related]
17. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546 [TBL] [Abstract][Full Text] [Related]
18. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143 [TBL] [Abstract][Full Text] [Related]
19. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626 [TBL] [Abstract][Full Text] [Related]